HomeTELO • CVE
add
Telo Genomics Corp
Previous close
$0.050
Year range
$0.040 - $0.13
Market cap
5.02M CAD
Avg Volume
64.62K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 526.62K | -17.17% |
Net income | -526.62K | 14.26% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -506.69K | 19.89% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 50.11K | -97.77% |
Total assets | 337.79K | -85.64% |
Total liabilities | 891.12K | 47.59% |
Total equity | -553.32K | — |
Shares outstanding | 100.43M | — |
Price to book | -5.00 | — |
Return on assets | -278.73% | — |
Return on capital | 628.84% | — |
Cash Flow
Net change in cash
| (CAD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -526.62K | 14.26% |
Cash from operations | -213.48K | 47.39% |
Cash from investing | -222.92K | — |
Cash from financing | — | — |
Net change in cash | -436.40K | -122.73% |
Free cash flow | -193.98K | -2.66% |
About
Founded
2011
Headquarters
Website
Employees
8
